 |
 |
|
The Solution for Dysfunctional Labor |
  |
 Bill & Melinda Gates Foundation supports research on the effect of the lactate concen-tration in amniotic fluid (AFL) on labor outcome, focusing on reducing maternal and infant mortality in developing countries. British BBC states:
"A test which could stop women labouring for hours in the hope of a "normal" birth only to end up with a Caesarean section has been developed in Sweden". Canadian TV highlights AFL-monitoring in an inteview with ObsteCare's CEO Johan Ubby Listen to the interview here >> |
About ObsteCare - Company OverviewObsteCare AB is a provider of medical solutions with a global focus on improving delivery care for both the mother and the healthcare provider. This is done by supplying reliable services and products, facilitating efficient care in maternity wards.
Experience
The company was founded on ground-breaking research at the Karolinska Institute, based upon the effect of lactate in the amniotic fluid of delivering mothers. The products originating from the research are the result of more than 20 years of in-depth knowledge of the practical situation in delivery wards.
Innovation
With focus on cutting-edge technology, ObsteCare provides innovative solutions helping to improve quality of care during the delivery process. The product line is built on a patented¹ technology and is the only solution available on the market for Point-of-Care use in monitoring lactate in amniotic fluid. Visions and Objectives
ObsteCare's vision is to be the World market-leader in the area of solutions and products for delivery care, for the benefit of the individual patient and the healthcare provider. Through continuous research and development, new solutions will be introduced and existing systems upgraded.
¹ US patent no. US 7,318,809 ¹ US patent pending no. 11/569,510 ¹ US patent pending no. 60/596,673 |
